vimarsana.com

Page 7 - Initial Coverage News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Original-Research: Cogia AG (von GBC AG): BUY

^ Original-Research: Cogia AG - von GBC AG Einstufung von GBC AG zu Cogia AG Unternehmen: Cogia AG ISIN: DE000A3H2226 Anlass der Studie: Research Report (Initial Coverage) Empfehlung: BUY Kursziel: 3.72 EUR Kursziel auf Sicht von: 31.12.2022 Letzte Ratingänderung: - Analyst: Matthias Greiffenber.

Investegate |Cogia AG Announcements | Cogia AG: Original-Research: Cogia AG (von GBC AG): BUY

Original-Research: IGEA Pharma N V (von GBC AG): BUY

Original-Research: IGEA Pharma N.V. - von GBC AG Einstufung von GBC AG zu IGEA Pharma N.V. Unternehmen: IGEA Pharma N.V. ISIN: NL0012768675 Anlass der Studie: Research Report (Initial Coverage)

Investegate |Cardiol Therapeutics Announcements | Cardiol Therapeutics: Original-Research: Cardiol Therapeutics (von GBC AG): BUY

Investegate |Cardiol Therapeutics Announcements | Cardiol Therapeutics: Original-Research: Cardiol Therapeutics (von GBC AG): BUY
investegate.co.uk - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from investegate.co.uk Daily Mail and Mail on Sunday newspapers.

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.